Cite

HARVARD Citation

    Perrone, F. et al. (2019). Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial. European journal of cancer. pp. 178-186. [Online]. 
  
Back to record